Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high209.875 27/05/16
52 week low23.875 09/03/17
52 week change -163.125 (-85.57%)
4 week volume6,181,043 03/03/17

Media for (AVO)

Presenter: Donatella Ungaro
15/12/2016
Presenter: Nicolas Serandour
13/10/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Additional financing agreement

RNS Number: 5406A Advanced Oncotherapy PLC 27 March 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Additional financing agreement Advanced Oncotherapy plc (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces that on Friday 24 March it signed an additional 12-...

Holding(s) in Company

RNS Number: 0037A Advanced Oncotherapy PLC 21 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Advanced Oncotherapy plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rig...

Hardman Research: Delivery of LIGHT

RNS Number: 4786Z Advanced Oncotherapy PLC 15 March 2017 Hardman Research: Delivery of LIGHT Delivery of LIGHT: AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage with construction work on its Harl...

Posting of Circular, Notice of GM and Update

RNS Number: 0859Z Advanced Oncotherapy PLC 10 March 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Posting of Circular, Notice of General Meeting and Update on Financing Options Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a ...

Investor presentation and Update

RNS Number: 6494Y Advanced Oncotherapy PLC 06 March 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Investor presentation and Update Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, will be hosting investor and analyst presentations in London later...

Conversion of convertible loan notes

RNS Number: 9959X Advanced Oncotherapy PLC 28 February 2017 28 February 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment G...

Broker Forecast - Beaufort Securities issues a broker note on Advanced Oncotherapy PLC

Beaufort Securities today downgrades its investment rating on Advanced Oncotherapy PLC (LON:AVO) to hold (from spe...

Update on financing and Harley Street

RNS Number: 7379X Advanced Oncotherapy PLC 24 February 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Financing and Harley Street building work update Advanced Oncotherapy plc (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces that further to the financing ...

Fundamental DataMore

EPS-0.51
Dividend yield0 %

Equity Research (AVO)

hardman & co
Advanced Oncotherapy Plc
15/03/2017
AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage...
Advanced Oncotherapy Plc
27/02/2017
PowerHouse Energy Group (PHE.L) 1p £8.94m PowerHouse has agreed with University of Chester to deploy its G3-UHt unit (ultra-high temperature demonstration gasification system)  at its Thornton...
hardman & co
Advanced Oncotherapy Plc
02/11/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...

Latest discussion posts More

  • Re: 1st Tranche

    I think the RNS of 22nd Feb needs clarification. I think the term tranches is misleading and it has been used just to make it easier to understand. As stated before each note ...
    14-Mar-2017
    spankaroo
  • Re: 1st Tranche

    "Drawdown of a trache of notes cannot be requested by either party without the written consent of the other unless (1) all previously issued notes have been converted in Ord ...
    14-Mar-2017
    Kenj2
  • Re: 1st Tranche

    ps re the conversion the whole 10 tranches need to be converted in the 12 months ie #13m worth. It can delay 2 of these tranches
    14-Mar-2017
    spankaroo

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.22%
SIRIUS MINERALS17%
BP12%
ROYAL BANK SCOT12%
BT GROUP12%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO